{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:03:01Z","timestamp":1790402581019,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T00:00:00Z","timestamp":1657843200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81830019"],"award-info":[{"award-number":["81830019"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7202188"],"award-info":[{"award-number":["7202188"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.biopha.2022.113433","type":"journal-article","created":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T14:49:55Z","timestamp":1658846995000},"page":"113433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Complement factor B inhibitor LNP023 improves lupus nephritis in MRL\/lpr mice"],"prefix":"10.1016","volume":"153","author":[{"given":"Keng","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunlai","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifeng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinggang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyuan","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangmei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2022.113433_bib1","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.kint.2016.03.042","article-title":"Insights into the epidemiology and management of lupus nephritis from the US rheumatologist\u2019s perspective","volume":"90","author":"Hoover","year":"2016","journal-title":"Kidney. Int."},{"key":"10.1016\/j.biopha.2022.113433_bib2","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/rheumatology\/kev311","article-title":"The frequency and outcome of lupus nephritis: results from an international inception cohort study","volume":"55","author":"Hanly","year":"2016","journal-title":"Rheumatology"},{"key":"10.1016\/j.biopha.2022.113433_bib3","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrrheum.2015.159","article-title":"What is damaging the kidney in lupus nephritis?","volume":"12","author":"Davidson","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.biopha.2022.113433_bib4","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJM200104053441406","article-title":"Complement. First of two parts","volume":"344","author":"Walport","year":"2001","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.biopha.2022.113433_bib5","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJM200104123441506","article-title":"Complement. Second of two parts","volume":"344","author":"Walport","year":"2001","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.biopha.2022.113433_bib6","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0889-857X(21)00155-1","article-title":"Genetics of systemic lupus erythematosus","volume":"18","author":"Arnett","year":"1992","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"10.1016\/j.biopha.2022.113433_bib7","doi-asserted-by":"crossref","first-page":"28540","DOI":"10.1074\/jbc.M704354200","article-title":"C4b-binding protein and factor H compensate for the loss of membrane-bound complement inhibitors to protect apoptotic cells against excessive complement attack","volume":"282","author":"Trouw","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"Suppl 3","key":"10.1016\/j.biopha.2022.113433_bib8","doi-asserted-by":"crossref","first-page":"S279","DOI":"10.1186\/ar586","article-title":"Complement and systemic lupus erythematosus","volume":"4","author":"Walport","year":"2002","journal-title":"Arthritis Res."},{"key":"10.1016\/j.biopha.2022.113433_bib9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1523-1755.2004.00371.x","article-title":"Effects of complement factor D deficiency on the renal disease of MRL\/lpr mice","volume":"65","author":"Elliott","year":"2004","journal-title":"Kidney Int."},{"key":"10.1016\/j.biopha.2022.113433_bib10","doi-asserted-by":"crossref","first-page":"786","DOI":"10.4049\/jimmunol.164.2.786","article-title":"Modulation of renal disease in MRL\/lpr mice genetically deficient in the alternative complement pathway factor B","volume":"164","author":"Watanabe","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2022.113433_bib11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF01893018","article-title":"Initiation of complement activation","volume":"7","author":"Lachmann","year":"1984","journal-title":"Springe Semin Immunopathol."},{"key":"10.1016\/j.biopha.2022.113433_bib12","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/ndt\/13.11.2799","article-title":"Acute nephrotoxic serum nephritis in complement knockout mice: relative roles of the classical and alternate pathways in neutrophil recruitment and proteinuria","volume":"13","author":"Hebert","year":"1998","journal-title":"Nephrol. Dial. Transpl."},{"key":"10.1016\/j.biopha.2022.113433_bib13","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1046\/j.1523-1755.1998.00723.x","article-title":"Immune complex glomerulonephritis in C4- and C3-deficient mice","volume":"53","author":"Quigg","year":"1998","journal-title":"Kidney Int."},{"key":"10.1016\/j.biopha.2022.113433_bib14","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1046\/j.1365-2249.1997.4261438.x","article-title":"Protection against anti-glomerular basement membrane (GBM)-mediated nephritis in C3- and C4-deficient mice","volume":"110","author":"Sheerin","year":"1997","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.biopha.2022.113433_bib15","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.4049\/jimmunol.160.9.4553","article-title":"Blockade of antibody-induced glomerulonephritis with Crry-Ig, a soluble murine complement inhibitor","volume":"160","author":"Quigg","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2022.113433_bib16","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1084\/jem.188.7.1321","article-title":"Transgenic mice overexpressing the complement inhibitor crry as a soluble protein are protected from antibody-induced glomerular injury","volume":"188","author":"Quigg","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biopha.2022.113433_bib17","doi-asserted-by":"crossref","first-page":"7926","DOI":"10.1073\/pnas.1820892116","article-title":"Small-molecule factor B inhibitor for the treatment of complement-mediated diseases","volume":"116","author":"Schubart","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2022.113433_bib18","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1681\/ASN.2014030233","article-title":"Deficiency of fibroblast growth factor-inducible 14 (Fn14) preserves the filtration barrier and ameliorates lupus nephritis","volume":"26","author":"Xia","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.biopha.2022.113433_bib19","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s13075-019-2038-0","article-title":"ALW peptide ameliorates lupus nephritis in MRL\/lpr mice","volume":"21","author":"Wang","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.biopha.2022.113433_bib20","doi-asserted-by":"crossref","first-page":"1 30 31","DOI":"10.1002\/cpbi.5","article-title":"The GeneCards suite: from gene data mining to disease genome sequence analyses","volume":"54","author":"Stelzer","year":"2016","journal-title":"Curr. Protoc. Bioinform."},{"key":"10.1016\/j.biopha.2022.113433_bib21","doi-asserted-by":"crossref","first-page":"1 2 1","DOI":"10.1002\/cpbi.27","article-title":"Searching online mendelian inheritance in man (OMIM): a knowledgebase of human genes and genetic phenotypes","volume":"58","author":"Amberger","year":"2017","journal-title":"Curr. Protoc. Bioinform."},{"key":"10.1016\/j.biopha.2022.113433_bib22","doi-asserted-by":"crossref","first-page":"D1388","DOI":"10.1093\/nar\/gkaa971","article-title":"PubChem in 2021: new data content and improved web interfaces","volume":"49","author":"Kim","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2022.113433_bib23","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1093\/bioinformatics\/btt540","article-title":"Shaping the interaction landscape of bioactive molecules","volume":"29","author":"Gfeller","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.biopha.2022.113433_bib24","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2022.113433_bib25","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/hep.30508","article-title":"The role of complement in liver injury, regeneration, and transplantation","volume":"70","author":"Thorgersen","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2022.113433_bib26","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.4049\/jimmunol.168.3.1036","article-title":"Complement C4 is protective for lupus disease independent of C3","volume":"168","author":"Einav","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2022.113433_bib27","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/ng0598-56","article-title":"Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies","volume":"19","author":"Botto","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.biopha.2022.113433_bib28","doi-asserted-by":"crossref","first-page":"5697","DOI":"10.1021\/acs.jmedchem.9b01870","article-title":"Discovery of 4-((2S,4S)-4-Ethoxy-1-((5-methoxy-7-methyl-1H-indol-4-yl)methyl)piperidin-2-yl)be nzoic Acid (LNP023), a factor B inhibitor specifically designed to be applicable to treating a diverse array of complement mediated diseases","volume":"63","author":"Mainolfi","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2022.113433_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102540","article-title":"Extracellular vesicles and lupus nephritis - New insights into pathophysiology and clinical implications","volume":"115","author":"Zhao","year":"2020","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.biopha.2022.113433_bib30","article-title":"Decrease of functional activated T and B cells and treatment of glomerulonephitis in lupus-prone mice using a natural flavonoid astilbin","volume":"10","author":"Guo","year":"2015","journal-title":"PLoS One"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222008228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222008228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T12:03:31Z","timestamp":1779969811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222008228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":30,"alternative-id":["S0753332222008228"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113433","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complement factor B inhibitor LNP023 improves lupus nephritis in MRL\/lpr mice","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113433","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"113433"}}